Psychopharmacology and Psychiatry Updates
A podcast by Psychopharmacology Institute
Categorie:
213 Episodio
-
Acute Agitation and Dexmedetomidine: A Novel Treatment Approach
Pubblicato: 30/8/2023 -
The Prevalence and Risks of RBD
Pubblicato: 25/8/2023 -
ADHD Medication and Their Role in Anxiety and Depression
Pubblicato: 20/8/2023 -
In the Realm of Sleep: RBD Diagnosis Explained
Pubblicato: 15/8/2023 -
NAC in Schizophrenia: Pie in the Sky or Groundbreaking Solution?
Pubblicato: 10/8/2023 -
Child Psychiatry: NAC and SAMe
Pubblicato: 5/8/2023 -
Youth Psychotropic Prescription Trends: Pandemic Influence
Pubblicato: 31/7/2023 -
Nature's Remedies in Youth: St. John's Wort and Valerian
Pubblicato: 26/7/2023 -
Exploring Serotonergic Antidepressants for PMDD
Pubblicato: 21/7/2023 -
Exploring Omega-3's Role in Child Psychiatry
Pubblicato: 16/7/2023 -
ADHD Meds for Preschoolers: Lisdexamfetamine
Pubblicato: 11/7/2023 -
Using Ginkgo Biloba in Children
Pubblicato: 6/7/2023 -
Examining COVID's Lasting Effects in Psychiatry
Pubblicato: 1/7/2023 -
Beyond SSRIs: Antipsychotic Augmentation in OCD
Pubblicato: 26/6/2023 -
Overcoming Barriers to Metabolic Monitoring in Youth Treated With SGAs
Pubblicato: 21/6/2023 -
Exploring Outcomes and Strategies in OCD Treatment After the First Trial
Pubblicato: 16/6/2023 -
Diving Into the APA Annual Meeting: Highlights and Insights!
Pubblicato: 11/6/2023 -
Exploring the Intriguing World of Microdosing Psilocybin
Pubblicato: 6/6/2023 -
SSRIs for OCD: A Closer Look at First-Line Treatment
Pubblicato: 1/6/2023 -
Exploring Nonstimulant Treatments for ADHD
Pubblicato: 27/5/2023
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.